Overview
- Revenue rose to Rs 854.4 crore in Q3 FY26, up 21% year on year, while profit after tax increased 8.5% to Rs 100.1 crore.
- Operating expenses climbed 18.4% to Rs 772.8 crore, reflecting scaling costs alongside top-line growth.
- Healthcare and Life Sciences accounted for 20% of revenue and grew 78% year on year, while BFSI contributed 12% with 26% growth.
- Adjusted EBITDA reached Rs 152.1 crore, up 24% year on year, with a 17.8% margin and a gross margin of 47.2%, both slightly higher than a year earlier.
- Client metrics strengthened, with Net Revenue Retention at 114%, an NPS of 77, six clients generating over $20 million in revenue, and 58 clients above $1 million.